Deformation patterns in genotyped patients with hypertrophic cardiomyopathy

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 4, 2014, Pages 456-465

  Geske, Jeffrey B ^a   Bos, J Martijn ^a   Gersh, Bernard J ^a   Ommen, Steve R ^a   Eidem, Benjamin W ^a   Ackerman, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Genetics; Hypertrophic cardiomyopathy; Strain

Indexed keywords

ADULT; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HEART EJECTION FRACTION; HEART PERFORMANCE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOFILAMENT; PRIORITY JOURNAL; STRAIN DIFFERENCE; TISSUE CHARACTERIZATION; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ECHOGRAPHY; GENETICS; HEART VENTRICLE; MUTATION; PHENOTYPE; PROCEDURES; PROSPECTIVE STUDY;

MYOSIN;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOSINS; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 84896985005     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jet234     Document Type: Article

References (42)

1. Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54:201-11
2. Van Driest SL,Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005;80:463-9
3. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001;33:655-70
4. Yiu KH, Atsma DE, Delgado V, Ng AC, Witkowski TG, Ewe SH et al. Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers. PLoS ONE 2012;7:e36115
5. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography -from technical considerations to clinical applications. J Am Soc Echocardiogr 2007;20:234-43
6. Kansal MM,Lester SJ, Surapaneni P, Sengupta PP, AppletonCP,Ommen SRet al. Usefulness of two-dimensional and speckle tracking echocardiography in 'Gray Zone' left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy. Am J Cardiol 2011;108:1322-6
7. Butz T, van Buuren F, Mellwig KP, Langer C, Plehn G, Meissner A et al. Twodimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: A study in athletes and in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2011;27:91-100
8. Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol 2007;100:128-32
9. Yang H, Sun JP, Lever HM, Popovic ZB, Drinko JK, Greenberg NL et al. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2003;16:233-9
10. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F et al. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circulation: Cardiovascular Genetics 2009;2:314-21
11. Solomon SD,Wolff S,Watkins H, Ridker PM, Come P, McKenna WJ et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated withmutations of the beta-myosin heavy chain gene. J AmColl Cardiol 1993;22: 498-505
12. Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 2006;81:459-67
13. Richardson P, McKennaW, Bristow M, Maisch B,Mautner B, O'Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-2
14. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study. J Am Coll Cardiol 1983;2:437-44
15. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43:1242-4
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63
17. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9
18. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997;10:246-70
19. Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 2008;21:1299-305
20. Saito M, Okayama H, Yoshii T, Higashi H, Morioka H, Hiasa G et al. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2012;13:617-23
21. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R et al. Global and regional myocardial function quantification by two-dimensional strain: Application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1175-81
22. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M et al. Twodimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 2004;17:1021-9
23. Van Driest SL, Jaeger MA, Ommen SR, Will ML, Gersh BJ, Tajik AJ et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:602-10
24. Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003;108:445-51
25. Van Driest SL, Vasile VC,OmmenSR, Will ML, Tajik AJ, Gersh BJ et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:1903-10
26. Battochio A, Mohammed S, Winthrop D, Lefresne S, Mulder K, ChuQ et al. Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: Comparison of DHPLC and DNA sequencing methods using a single population-based cohort. Am J Clin Pathol 2010;133:149-55
27. Taliani MR, Roberts SC, Dukek BA, Pruthi RK, Nichols WL, Heit JA. Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations. Genet Test 2001;5:39-44
28. Gross E, Arnold N, Pfeifer K, Bandick K, Kiechle M. Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 2000;16:345-53
29. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002;287: 1308-20
30. Maron BJ, Gardin JM, Flack JM, Gidding SS, KurosakiTT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92:785-9
31. Yang H, Carasso S,Woo A, Jamorski M, Nikonova A, Wigle ED et al. Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2010;23:1081-9
32. Ganame J, Pignatelli RH, EidemBW, Claus P, D'Hooge J, McMahon CJ et al. Myocardial deformation abnormalities in pediatric hypertrophic cardiomyopathy: Are all etiologies identical? Eur J Echocardiogr 2008;9:784-90
33. McLeod CJ, Bos JM, Theis JL, Edwards WD, Gersh BJ, Ommen SR et al. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J 2009;158:799-805
34. Blauwet LA, Ackerman MJ, EdwardsWD,Riehle DL,Ommen SR. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: Correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system. Cardiovasc Pathol 2009;18:262-8
35. Kobayashi T, Popovic Z, Bhonsale A, Smedira NG, Tan C, Rodriguez ER et al. Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy. Am Heart J 2013;166: 503-11
36. Abozguia K, Nallur-Shivu G, Phan TT, Ahmed I, Kalra R,Weaver RA et al. Left ventricular strain and untwist in hypertrophic cardiomyopathy: Relation to exercise capacity. Am Heart J 2010;159:825-32
37. Urbano Moral JA, Arias Godinez JA, Maron MS, Malik R, Eagan JE, Patel AR et al. Left ventricular twist mechanics in hypertrophic cardiomyopathy assessed by threedimensional speckle tracking echocardiography. Am J Cardiol 2011;108:1788-95
38. Pacileo G, Baldini L, Limongelli G, Di Salvo G, Iacomino M, Capogrosso C et al. Prolonged left ventricular twist in cardiomyopathies: A potential link between systolic and diastolic dysfunction. Eur J Echocardiogr 2011;12:841-9
39. Goto K, MikamiT, Onozuka H, Kaga S, Inoue M, KomatsuHet al. Role of left ventricular regional diastolic abnormalities for global diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2006;19:857-64
40. Bos JM, Subramaniam M, Hawse JR, Christiaans I, Rajamannan NM, Maleszewski JJ et al. TGFbeta-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy. J Cell Biochem 2012;113:1896-903
41. Wooten EC, Hebl VB,Wolf MJ, Greytak SR, Orr NM, Draper I et al. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. Circulation: Cardiovascular Genetics 2013;6:10-8
42. Purevjav E, ArimuraT, Augustin S, HubyAC, Takagi K,Nunoda S et al. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Hum Mol Genet 2012;21:2039-53